Artificial Intelligence in Clinical Trials

According to a study published in Trends in Pharmacological Sciences, computerized reasoning could enhance important aspects of the clinical preliminary procedure, such as patient selection, recruitment, and checking. Analysts observed that it takes between 10 and 15 years and costs between $1.5 billion and $2.0 billion to bring another pharmaceutical up for sale to the general public, with a portion of this time and money going towards clinical preliminary research. However, the study acknowledged that clinical preliminary exams continue to have high failure rates despite speculative claims.

  • Medical Imaging
  • Clinical study design
  • Research protocols
  • Biomarkers

Related Conference of Artificial Intelligence in Clinical Trials

September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France
October 31-01, 2024

37th World Congress on Pharmacology

Amsterdam, Netherlands
November 26-27, 2024

3rd World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2024

3rd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 28-29, 2024

12th International Conference on Clinical Trials

Vancouver, Canada
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
December 05-06, 2024

17th World Drug Delivery Summit

Dubai, UAE
February 24-25, 2025

2nd International Conference on Pharmacognosy

Madrid, Spain
March 10-11, 2025

35th Annual European Pharma Congress

Rome, Italy
March 13-14, 2025

8th International on Pharmacy and Pharmaceutical Conference

Prague, Czech Republic
April 14-15, 2025

18th European Biosimilars Congress

Paris, France
June 16-17, 2025

3rd Global Online Summit on Nanoscience and Nanotechnology

Zurich, Switzerland

Artificial Intelligence in Clinical Trials Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in